Cause:Acute change in elevation above at least 7000-8000 ft, by going up mountains, or in unpressurized airplanes (commercial airlines pressurized at 9000 ft); and usually w associated exertion
Pathophys:Cerebral edema from either cytotoxic vascular dilatation or change in bloodbrain barrier permeability (Jama 1998;280:1920). Normal pulmonary capillary wedge pressures; increased atrial natriuretic factor; increased capillary permeability (Ann IM 1988;109:796)
Increased incidence with exercise and cold weather; increased in teenagers (Nejm 1977;297:1269), patients w patent foramen ovale (Jama 2006;296:2954), and patients with congenital aplasia of right pulmonary artery (Nejm 1980;302:1070). Inhabitants of high altitudes can get just with 1-2 d at low altitudes and return. Physical conditioning before ascent has no effect on acute mountain sickness, pulmonary edema, or cerebral edema incidence. 22% incid at 7000-9000 ft, 42% at 10 000 ft.
Sx: Onset in 6-48 h; headache (62%); fatigue (26%) and lassitude; anorexia (11%), nausea, and vomiting; insomnia (31%); dyspnea (21%); dizziness (21%)
Si:Dyspnea; dry cough; Cheyne-Stokes respirations, esp at night. Acute pulmonary edema (4% of nonacclimatized people at 12 000-14 000 ft) without warning sis; cerebral edema w ataxia and confusion; asymptomatic retinal hemorrhages (Ophthalm 1992;99:739; Nejm 1970;282:1183)
Lab: ABGs:Respiratory alkalosis (on Everest, pH 7.4-7.53, PaCO2 as low as 13.3, PaO2 as low as 24.6 mm Hg) (Nejm 2009;360:140)
Xray:MRI of head in cerebral edema type shows white matter edema, esp of corpus callosum
Rx:
Prevent
of sx: most importantly, descend at least 1000 ft at 1st sx; O2
of pulmonary edema: prophylactic nifedipine 20 mg SR po q 8 h; decrease PA pressures (Nejm 1991;325:1284), eg w nitric oxide 10% inhalations (Nejm 1996;334:624); morphine im to relieve anxiety and pool peripheral blood; rest and descend
of cerebral edema: dexamethasone 8 mg po/iv, then 4 mg q 6 h; O2; immediate descent